Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

bPiDDB

Copy Product Info
😃Good
Catalog No. T37818Cas No. 525596-66-1
Alias N,N'-Dodecylbis-Picolinium Bromide

bPiDDB (N,N'-Dodecylbis-Picolinium Bromide) is a nicotinic receptor (nAChR) antagonist.

bPiDDB

bPiDDB

Copy Product Info
😃Good
Purity: 99.71%
Catalog No. T37818Alias N,N'-Dodecylbis-Picolinium BromideCas No. 525596-66-1
bPiDDB (N,N'-Dodecylbis-Picolinium Bromide) is a nicotinic receptor (nAChR) antagonist.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$33In StockIn Stock
10 mg$58In StockIn Stock
25 mg$119In StockIn Stock
50 mg$175In StockIn Stock
100 mg$260-In Stock
1 mL x 10 mM (in DMSO)$40In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.71%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

bPiDDB AI Summary
bPiDDB exhibits antagonist activity at nicotinic acetylcholine receptors (nAChR) in rat striatal slices, showing potent inhibition of nicotine-evoked [3H]dopamine release with an IC50 value of 2.0 nM. It demonstrates high affinity for the alpha4-beta2 subtype of nAChR, with a Ki value of 48600.0 nM, while showing considerably lower affinity for the alpha7 subtype, requiring concentrations greater than 100000.0 nM to displace ligands. In addition, bPiDDB inhibits nicotine-evoked [3H]dopamine overflow by up to 78.0% at a concentration of 100 uM and exhibits binding activity to the blood-brain barrier choline transporter with a Ki value of 36000.0 nM. These properties suggest its potential role in modulating cholinergic neurotransmission and dopamine signaling..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
bPiDDB (N,N'-Dodecylbis-Picolinium Bromide) is a nicotinic receptor (nAChR) antagonist.
SynonymsN,N'-Dodecylbis-Picolinium Bromide
Chemical Properties
Molecular Weight514.38
FormulaC24H38Br2N2
Cas No.525596-66-1
Smiles[Br-].[Br-].Cc1ccc[n+](CCCCCCCCCCCC[n+]2cccc(C)c2)c1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 5.15 mg/mL (10.01 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9441 mL9.7204 mL19.4409 mL97.2044 mL
5 mM0.3888 mL1.9441 mL3.8882 mL19.4409 mL
10 mM0.1944 mL0.9720 mL1.9441 mL9.7204 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy bPiDDB | purchase bPiDDB | bPiDDB cost | order bPiDDB | bPiDDB chemical structure | bPiDDB formula | bPiDDB molecular weight